Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults

Growth Hormone and IGF Research

Volumn 10, Issue 1, 2000, Pages 14-19

  Wieringa, G ^a   Toogood, A A ^a   Ryder, W D J ^a   Anderson, J M ^a   Mackness, M ^b   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Growth hormone treatment; Intra individual variation; Lipoprotein(a)

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; IMMUNOASSAY; LIPID ANALYSIS; MALE; PRIORITY JOURNAL; SAMPLING; STANDARDIZATION;

EID: 0034126096     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2000.0134     Document Type: Article

References (20)

1. Bengtsson B-A., Rosen T. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:1990;285-288.
2. J Am Med Ass. 251:1984;365-374.
3. Olivecrona H., Ericsson S., Berglund L., Angelin B. Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment. Br Med J. 306:1993;1726-1727.
4. Eden S., Wiklund S., Oscarsson J., Rosen T., Bengtsson B-A. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscl Thromb. 13:1993;296-301.
5. O'Halloran D. J., Wieringa G., Tsatsoulis A., Shalet S. M. Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment of patients with isolated GH deficiency. Ann Clin Biochem. 33:1996;330-335.
6. Russell-Jones D. L., Watts G. F., Weissberger A., Naoumova R., Myers J., Thompson G. R., Sonksen P. H. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient adults. Clin Endocrinol(Oxf). 41:1994;345-350.
7. Webster S. M., Stewart M., al-Maskari M., Osman I., Kendall-Taylor P., Mitcheson J., Laker M. F. Effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone deficient adults. Atherosclerosis. 133:1997;115-121.
8. Leese G. P., Wallymahmed M., Tames F., van Heyningen C., McFarlane I. A. Growth hormone replacement can reduce serum Lp(a) concentration. J Endocrinol Suppl. 1997;P190.
9. J Clin Endocrinol Metab. 83:1998;379-388.
10. Uterman G. The mysteries of lipoprotein(a). Science. 246:1989;904-910.
11. Kronenberg F., Trenkwalder E., Dieplinger H., Utermann G. Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol. 16:1996;1568-1572.
12. Dunn G. Design and analysis of reliability studies. Stat Meth Med Res. 1:1992;123-156.
13. Kearney E. M., Woolf-May K., Lawrence D., Ferbrace S. J., Bird S. R. Changes in Lp(a) concentration during exercise are assay dependent. Proc Int Congr Clin Chem. 1996;295.
14. Mackness M. I., Bhatnagar D., Wieringa G., MBewu A., Haynes B., Durrington P. N. A comparative study of six commercial lipoprotein(a) assays in seventeen laboratories within the British Isles. Ann Clin Bioch. 33:1996;63-71.
15. Pekelharing H. L., Aalders N. L., Visser G. H., van Doormaal J. J., Bouma B. N., Kleinveld H. A., van Rijn H. J. Method-dependent increase in lipoprotein(a) in insulin-dependent diabetes mellitus during pregnancy. Metabolism. 44:1995;1606-1611.
16. Albers J. J., Marcovina S. M. Standardisation of Lp(a) measurement. Chem Phys Lipids. 67/68:1994;265-270.
17. Marcovina S. M., Albers J. J., Gabel B., Koschinsky M. L., Gaur V. P. Effect of the number of apolipoprotein(a) Kringle 4 domains on immunochemical measurement of lipoprotein(a). Clin Chem. 41:1995;246-255.
18. Bard J-M., Delattre-Lestavel S., Clavey V. Isolation and characterisation of two sub-species of Lp(a), one containing apo E and one free of apo E. Biochim Biophys Acta. 1127:1992;124-130.
19. Fortmann S. P., Marcovina S. M. Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation. 95:1997;295-296.
20. Clin Chem. 44:1998;1629-1640.